Fairscale Capital »

SPDR S&P Biotech shares owned by Fairscale Capital

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Fairscale Capital from 13F filings

Historical chart of Fairscale Capital investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Fairscale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Fairscale Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1k 11 98.82
2024-06-30 $1.1k 11 101.82

More positions owned by Fairscale Capital

Vanguard S&p 500 Etf idx (VOO)
iShares S&P NA Tech. Sec. Idx (IGM)
NVIDIA Corporation (NVDA)
Vanguard Admiral Fds Inc equity (VOOV)
Apple (AAPL)
Pacer Fds Tr us cash cows 100 (COWZ)
Microsoft Corporation (MSFT)
Invesco Qqq Trust Series 1 (QQQ)
Visa (V)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Schwab Strategic Tr us dividend eq (SCHD)
Thermo Fisher Scientific (TMO)
UnitedHealth (UNH)
Facebook Inc cl a (META)

View all positions for Fairscale Capital

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Bank of America Corporation
Citigroup
Citadel Advisors
Morgan Stanley
Millennium Management
Bnp Paribas Arbitrage, Snc
Susquehanna International
Healthcare Of Ontario Pension Plan Trust Fund
Twin Tree Management
Parallax Volatility Advisers
Logos Global Management
Balyasny Asset Management
Wells Fargo & Company

View all funds holding SPDR S&P Biotech